Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Leases (2019 - 2022)

NovaBridge Biosciences (NBP) has disclosed Leases for 4 consecutive years, with $8.9 million as the latest value for Q4 2022.

  • Quarterly Leases fell 49.68% to $8.9 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $8.9 million through Dec 2022, down 49.68% year-over-year, with the annual reading at $9.2 million for FY2022, 48.29% down from the prior year.
  • Leases for Q4 2022 was $8.9 million at NovaBridge Biosciences, down from $17.6 million in the prior quarter.
  • The five-year high for Leases was $17.6 million in Q4 2021, with the low at $2.3 million in Q4 2020.
  • Average Leases over 4 years is $7.8 million, with a median of $5.6 million recorded in 2019.
  • The sharpest move saw Leases surged 679.52% in 2021, then tumbled 49.68% in 2022.
  • Over 4 years, Leases stood at $2.3 million in 2019, then decreased by 2.95% to $2.3 million in 2020, then soared by 679.52% to $17.6 million in 2021, then crashed by 49.68% to $8.9 million in 2022.
  • According to Business Quant data, Leases over the past three periods came in at $8.9 million, $17.6 million, and $2.3 million for Q4 2022, Q4 2021, and Q4 2020 respectively.